by | PRNewswire Asia
Study confirms the novelty and atomic-level precision of de novo antibody design, including cryo-EM validation on a designed anti-PD-L1 antibody Findings highlight broad therapeutic applicability across oncology, immune, and metabolic diseases SEOUL, South Korea,...
by | PRNewswire Asia
BANGKOK, Sept. 22, 2025 /PRNewswire/ — COSMEX 2025, ASEAN’s most comprehensive event on OEM service and manufacturing technology for cosmetic, personal care, and dietary supplement products, packaging, printing, labelling, finished product, and beauty...
by | PRNewswire Asia
Unveiling AI architecture for virtual makeup, skin prediction algorithms, and fresh perspectives to skin aging research SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ — At the 35th International Federation of Societies of Cosmetics Chemists (IFSCC) Congress...
by | PRNewswire Asia
GUANG’AN, China, Sept. 22, 2025 /PRNewswire/ — PHASE Scientific International Limited ("PHASE Scientific") today announced the official launch of the world’s largest clinical study for urine-based cervical cancer (HPV) screening, with...
by | PRNewswire Asia
SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ — Do you ever feel like you’re doing too much for your skin yet still battling dryness? You’re not alone. In 2025, many people are discovering that dryness isn’t a sign you need a skincare...
by | PRNewswire Asia
HONG KONG, Sept. 22, 2025 /PRNewswire/ — Akeso Inc. (9926.HK) has announced that the first patient has been dosed in its registrational Phase II study (AK130-202), evaluating AK130, a fully independently developed TIGIT/TGF-β bifunctional antibody fusion...
